Glofitamab,Atezolizumab,Polatuzumab Vedotin,Obinutuzumab,Tocilizumab,89Zr-Df-IAB22M2C
Roche,Imaginab,JW Pharma
['dlbcl', 'polatuzumab', 'glofitamab', 'pola', 'cml']
#17icml np39488 glofitamab and polatuzumab. bispecifics combine with chemotherapy. the way to get deeper and longer responses in dlbcl. 
Happily married. Hematologist & SC Transplanter. field of interest: lymphoma-myeloma &chemoresistance biomarkers. @HematoClinicBCN @hematosantpau.@GELL01433166